Antithrombotic therapy in cardiovascular diseases. Future directions based on pathogenesis and risk.
Ip
J H
JH
Division of Cardiology, Mount Sinai Medical Center, New York, New York 10029.
Stein
B
B
Fuster
V
V
Badimon
L
L
D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D003331:Coronary Vessels / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006350:Heart Valve Prosthesis; D006801:Humans; D008954:Models, Biological; D012307:Risk Factors; D013927:Thrombosis / Q000188:drug therapy
D005343:Fibrinolytic Agents